...its largest shareholder; underwriters are BMO Capital Markets, Wells Fargo and UBS. Spun out of Flexus Biosciences Inc....

...with cell type-specific expression guided by encoded 'if', 'and', or 'or' logic gates. Allison Johnson, Senior Writer Flexus Biosciences Inc. Fulcrum...

...Discovery David Wustrow became SVP of drug discovery and preclinical development. RAPT spun out of Flexus Biosciences Inc....

...to the antibody. Arcus founders Terry Rosen and Juan Jaen also founded cancer immunotherapy company Flexus Biosciences Inc....

...June 7) . Arcus founders Terry Rosen and Juan Jaen also founded cancer immunotherapy company Flexus Biosciences Inc....

...dominating the immuno-oncology space. Armed with $79 million in series A and B funds, the Flexus Biosciences Inc....
...targeting Tregs and myeloid-derived suppressor cells Disease focus: Cancer Clinical status: Preclinical Founded: 2015 by Flexus Biosciences Inc....
...at the annual meeting of the American Association for Cancer Research (2017) Karen Tkach Tuzman, Senior Writer Flexus Biosciences Inc. RAPT...

...Association for Cancer Research meeting in Washington, D.C. BMS gained BMS-986205 through its acquisition of Flexus Biosciences Inc....

...prove that they have combinations,” Loncar said. Bristol-Myers gained BMS-986205 through its 2015 acquisition of Flexus Biosciences Inc....

...to the clinic, but declined to disclose specific indications. Rosen was CEO at immunotherapy company Flexus BioSciences Inc....

...Venture backers of Flexus Biosciences Inc. are back for round two with spinout FLX Bio Inc. This time...